Restenosis after femoropopliteal PTA and elective stent implantation: Predictive value of monocyte counts

Journal of Endovascular Therapy

Volumn 10, Issue 3, 2003, Pages 557-565

  Schillinger, Martin ^a   Exner, Markus ^a   Mlekusch, Wolfgang ^a   Haumer, Markus ^a   Sabeti, Schila ^a   Ahmadi, Ramazanali ^a   Schwarzinger, Ilse ^a   Wagner, Oswald ^a   Minar, Erich ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Angioplasty; Femoropopliteal segment; Monocytes; Occlusion; Outcome analysis; Restenosis; Stenosis; Stents

Indexed keywords

ADULT; AGED; ARTERY DIAMETER; ARTERY DISEASE; ARTICLE; FEMALE; FEMOROPOPLITEAL PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; FOLLOW UP; HUMAN; IMPLANTATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MULTIVARIATE ANALYSIS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RESTENOSIS; RISK ASSESSMENT; STENT; TREATMENT OUTCOME;

AGED; ANGIOPLASTY; ARTERIAL OCCLUSIVE DISEASES; FEMALE; FEMORAL ARTERY; FOLLOW-UP STUDIES; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MONOCYTES; POPLITEAL ARTERY; PREDICTIVE VALUE OF TESTS; RECURRENCE; STENTS; SURGICAL PROCEDURES, ELECTIVE;

EID: 0141702224     PISSN: 15266028     EISSN: None     Source Type: Journal    
DOI: 10.1583/1545-1550(2003)010<0557:RAFPAE>2.0.CO;2     Document Type: Article

References (30)

1. Maca T, Ahmadi R, Derfler K, et al. Elevated lipoprotein(a) and increased incidence of restenosis after femoropopliteal PTA. Rationale for the higher risk of recurrence in females? Atherosclerosis. 1996;127:27-34.
2. Gallino A, Mahler F, Probst P, et al. Percutaneous transluminal angioplasty of the arteries of the lower limbs: a 5 year follow-up. Circulation. 1984;70:619-623.
3. Krepel VM, van Andel GJ, van Erp WF, et al. Percutaneous transluminal angioplasty of femoropopliteal artery: initial and long-term results. Radiology. 1985;156:325-328.
4. Cejna M, Thurnher SA, Illiasch H, et al. PTA versus Palmaz stent placement in femoropopliteal artery obstructions: a multicenter prospective randomized study. J Vasc Interv Radiol. 2001;12:23-31.
5. Orford JL, Selwyn AP, Ganz P, et al. The comparative pathobiology of atherosclerosis and restenosis. Am J Cardiol. 2000;86:6H-11H.
6. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999;340:115-126.
7. O'Brian ER, Schwartz SM. Update of the biology and clinical study of restenosis. Trends Cardiovasc Med. 1994;4:169-178.
8. Forrester JS, Fishbein M, Helfant R, et al. A paradigm for restenosis based on cell biological clues for the development of new preventive therapies. J Am Coll Cardiol. 1991;17:758-769.
9. Lusis AJ. Atherosclerosis. Nature. 2000;407:233-241.
10. Libby P, Ridker P, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135-1143.
11. Glass CK, Witztum JL. Atherosclerosis: the road ahead. Cell. 2001;104:503-516.
12. Arefieva TI, Provatorov SI, Samko AN, et al. Monocyte integrin expression and monocyte-platelet complex formation in humans with coronary restenosis. Clin Exp Pharmacol Physiol. 2001;28:804-808.
13. TASC Working Group. Management of peripheral arterial disease (PAD). TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000;31:S1-S296.
14. Minar E, Pokrajac B, Maca T, et al. Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty: results of a prospective randomized study. Circulation. 2000;102:2694-2699.
15. Schillinger M, Exner M, Mlekusch W, et al. Vascular inflammation and percutaneous transluminal angioplasty of the femoropopliteal artery: association with restenosis. Radiology. 2002;225:21-26.
16. Schillinger M, Mlekusch W, Haumer M, et al. Angioplasty and elective stenting of de novo versus recurrent femoropopliteal lesions: 1-year follow-up. J Endovasc Ther. 2003;10:288-297.
17. Ranke C, Creutzig A, Alexander K. Duplex scanning of the peripheral arteries: correlation of the peak velocity ratio with angiographic diameter reduction. Ultrasound Med Biol. 1992;18:433-440.
18. Exner M, Schillinger M, Minar E, et al. Heme oxygenase-1 gene promoter microsatellite polymorphism is associated with restenosis after percutaneous transluminal angioplasty. J Endovasc Ther. 2001;8:433-440.
19. Schillinger M, Haumer M, Schlerka G, et al. Restenosis after percutaneous transluminal angioplasty in the femoropopliteal segment: the role of inflammation. J Endovasc Ther. 2001;8:477-483.
20. Minar E, Pokrajac B, Ahmadi R, et al. Brachytherapy for prophylaxis of restenosis after long-segment femoropopliteal angioplasty: pilot study. Radiology. 1998;208:173-179.
21. Serrano CV, Ramires JA, Venturinelli M, et al. Coronary angioplasty results in leucocyte and platelet activation with adhesion molecule expression. Evidence of inflammatory responses in coronary angioplasty. J Am Coll Cardiol. 1997;29:1276-1283.
22. Kornowski R, Hong MK, Tio FO, et al. In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol. 1998;31:224-230.
23. Yutani C, Ishibashi-Ueda H, Suzuki T, et al. Histologic evidence of foreign body granulation tissue and de novo lesions in patients with coronary stent stenosis. Cardiology. 1999;92:171-177.
24. Belch JJ, Shaw JW, Kirk G, et al. The white blood cell adhesion molecule E-selectin predicts restenosis in patients with intermittent claudication undergoing percutaneous transluminal angioplasty. Circulation. 1997;95:2027-2031.
25. Kamijikkoku S, Murohara T, Tayama S, et al. Acute myocardial infarction and increased soluble intercellular adhesion molecule-1: a marker of vascular inflammation and risk of early restenosis? Am Heart J. 1998;136:231-236.
26. Tsakiris DA, Tschopl M, Jager K, et al. Circulating cell adhesion molecules and endothelial markers before and after transluminal angioplasty in peripheral arterial occlusive disease. Atherosclerosis. 1999;142:193-200.
27. Cipollone F, Marini M, Fazia M, et al. Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. Arterioscler Thromb Vasc Biol. 2001;21:327-334.
28. Mickelson JK, Lakkis NM, Villarreal-Levy G, et al. Leukocyte activation with platelet adhesion after coronary angioplasty: a mechanism for recurrent disease? J Am Coll Cardiol. 1996;28:345-353.
29. Pietersma A, Kofflard M, de Wit LE, et al. Late lumen loss after coronary angioplasty is associated with the activation status of circulating phagocytes before treatment. Circulation. 1995;91:1320-1325.
30. Wilcox JN, Okamoto EI, Nakahara KI, et al. Perivascular responses after angioplasty which may contribute to postangioplasty restenosis: a role for circulating myofibroblasts precursors? Ann N Y Acad Sci. 2001;947:68-90.